Literature DB >> 25488794

Recent advancements in and views on the donor operation in living donor liver transplantation: a single-center study of 886 patients over 13 years.

Kyung-Suk Suh1, Suk-Won Suh, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee.   

Abstract

Donor safety remains an important concern in living donor liver transplantation (LDLT). In the present study, we assessed recent advancements in the donor operation for LDLT through our experience with this procedure. A total of 886 donor hepatectomies performed between January 1999 and December 2012 were analyzed. Three chronological periods were investigated: the initial period (1999-2004, n = 239), the period in which the right liver with middle hepatic vein reconstruction was primarily used (2005-2010, n = 422), and the period in which the right liver with a standardized protocol, including a preoperative donor diet program, an evaluation of steatosis with magnetic resonance spectroscopy, no systemic heparin administration or central venous pressure monitoring, exact midplane dissection, and incremental application of minimal incisions, was exclusively used (2011-2012, n = 225). The proportion of patients > 50 years old increased (2.5% versus 4.7% versus 8.9%), whereas the proportion of patients with a remnant liver volume ≤ 30% (6.5% versus 13.9% versus 6.3%) and with macrosteatosis ≥ 10% (7.9% versus 11.1% versus 4.4%) decreased throughout the periods. The operative time (292.7 versus 290.0 versus 272.8 minutes), hospital stay (12.4 versus 11.2 versus 8.5 days), and overall morbidity rate (26.4% versus 13.3% versus 5.8%), including major complications (>grade 3; 1.7% versus 1.9% versus 0.9%) and biliary complications (7.9% versus 5.0% versus 0.9%), were markedly reduced in the most recent period. No intraoperative transfusion was required. No cases of irreversible disability or mortality were noted. In conclusion, the quality of the donor operation has recently been standardized through a large volume of experience, and the operation has been proven to have minimal risk. However, a constant evaluation of our experience is critical for remaining prepared for any unavoidable crisis.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25488794     DOI: 10.1002/lt.24061

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  13 in total

1.  Selection and outcome of the potential live liver donor.

Authors:  Viniyendra Pamecha; Shyam Sunder Mahansaria; Kishore G S Bharathy; Senthil Kumar; Shridhar Vasantrao Sasturkar; Piyush Kumar Sinha; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2016-03-17       Impact factor: 6.047

Review 2.  Adult living donor liver imaging.

Authors:  Larry Cai; Benjamin M Yeh; Antonio C Westphalen; John P Roberts; Zhen J Wang
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

3.  Liver Living Donation for Cancer Patients: Benefits, Risks, Justification.

Authors:  Silvio Nadalin; Lara Genedy; Alfred Königsrainer
Journal:  Recent Results Cancer Res       Date:  2021

4.  Living donor liver transplantation for hepatocellular carcinoma in Seoul National University.

Authors:  Suk Kyun Hong; Kwang-Woong Lee; Hyo-Sin Kim; Kyung Chul Yoon; Nam-Joon Yi; Kyung-Suk Suh
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

5.  Complications and outcomes of 890 living liver donor hepatectomies at a single center: risks of saving loved one's life.

Authors:  Yücel Yankol; Nesimi Mecit; Turan Kanmaz; Münci Kalayoğlu; Koray Acarlı
Journal:  Turk J Surg       Date:  2020-06-08

Review 6.  Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation.

Authors:  Toru Ikegami; Jong Man Kim; Dong-Hwan Jung; Yuji Soejima; Dong-Sik Kim; Jae-Won Joh; Sung-Gyu Lee; Tomoharu Yoshizumi; Masaki Mori
Journal:  Korean J Transplant       Date:  2019-12-31

7.  Pure laparoscopic donor right hepatectomy in a living donor with type 3a biliary variation: A case report.

Authors:  Young Seok Han; Heontak Ha; Hyung Jun Kwon; Jae Min Chun
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

8.  Which is better to use "body weight" or "standard liver weight", for predicting small-for-size graft syndrome after living donor liver transplantation?

Authors:  Takeo Toshima; Tomoharu Yoshizumi; Tomonari Shimagaki; Huanlin Wang; Takeshi Kurihara; Yoshihiro Nagao; Shinji Itoh; Noboru Harada; Masaki Mori
Journal:  Ann Gastroenterol Surg       Date:  2020-12-11

Review 9.  Should living donor liver transplantation be an option when deceased donation is not?

Authors:  Sarah R Lieber; Thomas D Schiano; Rosamond Rhodes
Journal:  J Hepatol       Date:  2017-11-01       Impact factor: 30.083

10.  Influence of Body Mass Index ≥30 on Pure Laparoscopic Donor Right Hepatectomy.

Authors:  Suk Kyun Hong; Kyung-Suk Suh; Jae-Hyung Cho; Jeong-Moo Lee; Nam-Joon Yi; Kwang-Woong Lee
Journal:  Ann Transplant       Date:  2020-06-02       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.